West Pharmaceutical Services WST
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
West Pharmaceutical Services (WST) Business Model and Operations Summary
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Key Insights
West Pharmaceutical Services (WST) Core Market Data and Business Metrics
Latest Closing Price
$220.16Market Cap
$15.92 BillionPrice-Earnings Ratio
32.91Total Outstanding Shares
72.29 Million SharesTotal Employees
10,600Dividend
$0.21 Per Share QuarterlyIPO Date
October 27, 1980SIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
530 Herman O. West Drive, Exton, PA, 19341
Historical Stock Splits
If you bought 1 share of WST before September 27, 2013, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| September 27, 2013 | 2-for-1 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $653.40 Million |
| Net Cash Flow From Investing Activities, Continuing | $-378.70 Million |
| Net Cash Flow From Investing Activities | $-378.70 Million |
| Net Cash Flow From Financing Activities, Continuing | $-622.60 Million |
| Net Cash Flow From Operating Activities | $653.40 Million |
| Net Cash Flow From Financing Activities | $-622.60 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Basic Earnings Per Share | $6.75 |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Selling, General, and Administrative Expenses | $338.50 Million |
| Research and Development | $69.10 Million |
| Income/Loss Before Equity Method Investments | $585.50 Million |
| Operating Income/Loss | $569.90 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $378.40 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-114.30 Million |
| Comprehensive Income/Loss Attributable To Parent | $378.40 Million |
| Other Comprehensive Income/Loss | $378.40 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $3.64 Billion |
| Other Current Liabilities | $311.10 Million |
| Intangible Assets | $10.80 Million |
| Liabilities And Equity | $3.64 Billion |
| Liabilities | $961.10 Million |
| Other Non-current Assets | $512.90 Million |
Historical Dividends
Current dividend: $0.21 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 20, 2025 | May 7, 2025 | Apr 30, 2025 | $0.21 | Quarterly |
| Jan 28, 2025 | Feb 11, 2025 | Feb 7, 2025 | $0.21 | Quarterly |
| Oct 24, 2024 | Nov 20, 2024 | Nov 13, 2024 | $0.21 | Quarterly |
| Apr 25, 2024 | Aug 7, 2024 | Jul 31, 2024 | $0.2 | Quarterly |
| Feb 20, 2024 | May 1, 2024 | Apr 24, 2024 | $0.2 | Quarterly |
| Dec 6, 2023 | Feb 7, 2024 | Jan 31, 2024 | $0.2 | Quarterly |